CRLBF logo

Cresco Labs Inc. (CRLBF)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cresco Labs Inc. (CRLBF) with AI Score 45/100 (Weak). Cresco Labs Inc. cultivates, manufactures, and sells cannabis products in the United States. Market cap: 0, Sector: Healthcare.

Last analyzed: Mar 16, 2026
Cresco Labs Inc. cultivates, manufactures, and sells cannabis products in the United States. The company offers a variety of cannabis products, including flowers, vape pens, edibles, and extracts, catering to both retail and medical markets.
45/100 AI Score

Cresco Labs Inc. (CRLBF) Healthcare & Pipeline Overview

CEOCharles Bachtell
Employees2900
HeadquartersChicago, US
IPO Year2018

Cresco Labs Inc. is a U.S.-based cannabis company focused on cultivation, manufacturing, and retail. With a diverse portfolio of cannabis products and brands, Cresco Labs operates in key markets, serving both medical and recreational consumers. The company faces evolving regulatory landscapes and intense competition in the expanding cannabis industry.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Mar 16, 2026

Investment Thesis

Cresco Labs presents a mixed investment thesis. The company's diverse brand portfolio and retail footprint offer growth potential in the expanding cannabis market. However, the negative P/E ratio of -2.40 and a negative profit margin of -21.0% raise concerns about profitability. The company's high beta of 1.64 indicates higher volatility compared to the broader market. Upcoming catalysts include potential regulatory changes and market expansion opportunities. Investors should closely monitor Cresco Labs' progress towards profitability and its ability to navigate the evolving regulatory landscape.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $0.33B reflects its current valuation in the cannabis market.
  • P/E Ratio of -2.40 indicates the company is currently not profitable.
  • Gross Margin of 48.7% suggests strong pricing power and efficient production.
  • Beta of 1.64 indicates higher volatility compared to the broader market.
  • Operates 48 dispensaries as of January 27, 2022, providing a direct retail channel.

Competitors & Peers

Strengths

  • Diverse brand portfolio catering to different consumer segments.
  • Established retail footprint with owned and operated dispensaries.
  • Strong cultivation and manufacturing capabilities.
  • Experienced management team with a track record of growth.

Weaknesses

  • Negative profitability and high operating expenses.
  • High debt levels and limited access to capital.
  • Exposure to regulatory risks and uncertainties.
  • Intense competition in the cannabis industry.

Catalysts

  • Upcoming: Potential changes in federal cannabis regulations could open new markets and reduce operational burdens.
  • Ongoing: Expansion of retail footprint through new dispensary openings in key states.
  • Ongoing: Development and launch of new cannabis products and brands.
  • Ongoing: Strategic acquisitions of other cannabis companies to expand market share.

Risks

  • Potential: Regulatory changes could negatively impact the cannabis industry.
  • Ongoing: Intense competition from other cannabis companies.
  • Ongoing: Fluctuations in cannabis prices could affect profitability.
  • Ongoing: Limited access to capital due to federal cannabis prohibition.
  • Potential: Negative public perception of cannabis could limit market growth.

Growth Opportunities

  • Expansion into New Markets: As more states legalize cannabis, Cresco Labs has the opportunity to expand its operations into new markets. This expansion could involve acquiring existing dispensaries, establishing new cultivation facilities, or partnering with local operators. The timeline for this growth opportunity depends on the pace of legalization in different states. The market size for new cannabis markets is estimated to be billions of dollars annually.
  • Product Innovation and Development: Cresco Labs can drive growth by developing new and innovative cannabis products. This could include new strains of cannabis, new delivery methods, or new cannabis-infused products. The company's research and development efforts can help it stay ahead of the competition and meet evolving consumer preferences. The market for new cannabis products is estimated to be worth hundreds of millions of dollars annually.
  • Strategic Acquisitions: Cresco Labs can grow through strategic acquisitions of other cannabis companies. This could involve acquiring companies with complementary assets, such as cultivation facilities, dispensaries, or brands. Acquisitions can help Cresco Labs expand its market share and geographic reach. The timeline for this growth opportunity depends on the availability of suitable acquisition targets. The market for cannabis acquisitions is estimated to be worth billions of dollars.
  • Increased Retail Footprint: Cresco Labs can increase its revenue by expanding its retail footprint. This could involve opening new dispensaries in existing markets or entering new markets. The company's retail strategy should focus on providing a positive customer experience and offering a wide selection of cannabis products. The timeline for this growth opportunity depends on the availability of suitable retail locations and regulatory approvals. The market for cannabis retail is estimated to be worth billions of dollars annually.
  • Development of Branded Products: Cresco Labs can capitalize on its established brands by developing new products under those brands. This could involve extending existing product lines or creating entirely new product categories. The company's brand recognition and customer loyalty can help it drive sales of new branded products. The timeline for this growth opportunity depends on the company's product development cycle. The market for branded cannabis products is estimated to be worth billions of dollars annually.

Opportunities

  • Expansion into new markets through legalization.
  • Development of new and innovative cannabis products.
  • Strategic acquisitions of other cannabis companies.
  • Increased brand awareness and customer loyalty.

Threats

  • Changing regulations and government policies.
  • Increased competition from other cannabis companies.
  • Fluctuations in cannabis prices.
  • Negative public perception of cannabis.

Competitive Advantages

  • Brand Portfolio: Cresco Labs has a diverse portfolio of established cannabis brands.
  • Retail Footprint: Cresco Labs owns and operates a network of dispensaries.
  • Cultivation and Manufacturing Expertise: Cresco Labs has expertise in cultivating cannabis and manufacturing cannabis products.
  • Regulatory Compliance: Cresco Labs has a strong track record of regulatory compliance.

About CRLBF

Founded in 2013 and headquartered in Chicago, Illinois, Cresco Labs Inc. has emerged as a significant player in the U.S. cannabis industry. The company cultivates, manufactures, and sells a wide range of cannabis products, catering to both the retail and medical markets. Cresco Labs' brand portfolio includes Cresco, High Supply, Good News, Wonder Wellness Co., Remedi, Reserve, FloraCal, and Mindy's Edibles, each targeting different consumer preferences and product categories. These brands offer cannabis in various forms, including flowers, vape pens, edibles, extracts, tinctures, and topicals. Cresco Labs also licenses the Kiva brand, known for its cannabis-infused edibles. As of January 27, 2022, Cresco Labs owned and operated 48 dispensaries, providing direct access to consumers in key markets. The company's strategic focus on brand development, product innovation, and retail expansion has contributed to its growth in the competitive cannabis market.

What They Do

  • Cultivates cannabis plants in controlled environments.
  • Manufactures a variety of cannabis products, including flowers, vape pens, edibles, and extracts.
  • Sells cannabis products through its own dispensaries and wholesale channels.
  • Develops and markets branded cannabis products, such as Cresco, High Supply, and Good News.
  • Licenses its brands to other cannabis companies.
  • Operates retail dispensaries under the Sunnyside brand.

Business Model

  • Cultivation and Manufacturing: Cresco Labs grows cannabis and manufactures cannabis products.
  • Retail Sales: Cresco Labs sells cannabis products through its own dispensaries.
  • Wholesale Distribution: Cresco Labs sells cannabis products to other dispensaries and retailers.
  • Brand Licensing: Cresco Labs licenses its brands to other cannabis companies.

Industry Context

The U.S. cannabis industry is experiencing rapid growth, driven by increasing legalization and consumer acceptance. Cresco Labs operates in a competitive landscape that includes both established players and emerging companies. The industry is subject to evolving regulations, which can create both opportunities and challenges for cannabis companies. Market trends include the growing popularity of cannabis-infused products, such as edibles and beverages, and the increasing demand for medical cannabis. Cresco Labs' focus on brand development and retail expansion positions it to capitalize on these trends.

Key Customers

  • Retail Consumers: Individuals purchasing cannabis for recreational or medical use.
  • Medical Patients: Individuals with medical cannabis prescriptions.
  • Wholesale Partners: Other dispensaries and retailers that sell Cresco Labs' products.
AI Confidence: 81% Updated: Mar 16, 2026

Financials

Chart & Info

Cresco Labs Inc. (CRLBF) stock price: Price data unavailable

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CRLBF.

Price Targets

Wall Street price target analysis for CRLBF.

MoonshotScore

45/100

What does this score mean?

The MoonshotScore rates CRLBF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Classification

Sector Healthcare Industry Drug Manufacturers - Specialty & Generic

Latest News

Leadership: Charles Bachtell

CEO

Charles Bachtell is the CEO of Cresco Labs. His background includes experience in the legal and regulatory aspects of the cannabis industry. He has been instrumental in guiding Cresco Labs through its growth phase, navigating the complex regulatory landscape, and establishing the company as a leading player in the U.S. cannabis market. Bachtell's leadership focuses on strategic expansion, brand development, and operational efficiency.

Track Record: Under Charles Bachtell's leadership, Cresco Labs has expanded its retail footprint, developed a diverse portfolio of cannabis brands, and achieved significant revenue growth. He has overseen strategic acquisitions and partnerships that have strengthened the company's market position. Bachtell has also focused on building a strong corporate culture and promoting responsible business practices.

CRLBF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Cresco Labs may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies on this tier may have limited trading volume and liquidity compared to those on regulated exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for less transparency and greater price volatility. This tier is often populated by shell companies, bankrupt entities, or companies with questionable operations.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: As an OTC stock, CRLBF may experience lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at a desired price. Investors should be aware of the potential for price volatility and illiquidity when trading CRLBF on the OTC market. Executing large trades may significantly impact the stock price.
OTC Risk Factors:
  • Limited disclosure requirements compared to listed exchanges.
  • Lower trading volume and liquidity, leading to price volatility.
  • Potential for less transparency and greater information asymmetry.
  • Higher risk of fraud or manipulation.
  • OTC Other tier companies may have financial difficulties or operational challenges.
Due Diligence Checklist:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's regulatory compliance and legal risks.
  • Monitor the stock's trading volume and price volatility.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with investing in OTC stocks.
Legitimacy Signals:
  • Established operations in the cannabis industry.
  • Presence of a recognized management team.
  • Publicly available information, such as press releases and investor presentations.
  • Audited financial statements (if available).
  • Positive media coverage and industry recognition.

Cresco Labs Inc. Stock: Key Questions Answered

What does Cresco Labs Inc. do?

Cresco Labs Inc. cultivates, manufactures, and sells a variety of cannabis products in the United States. Their product range includes cannabis flowers, vape pens, edibles, extracts, tinctures, and topicals, catering to both the retail and medical markets. They operate through a portfolio of brands, including Cresco, High Supply, Good News, and Mindy's Edibles, and also own and operate a network of dispensaries under the Sunnyside brand. Cresco Labs focuses on delivering quality cannabis products and building strong brand recognition in the competitive cannabis industry.

What do analysts say about CRLBF stock?

Analyst coverage of CRLBF is limited due to its OTC listing. However, general sentiment reflects the potential for growth in the cannabis market, balanced against the risks of regulatory uncertainty and intense competition. Key valuation metrics, such as price-to-sales ratio, are often used to assess cannabis companies due to the current lack of profitability for many players in the industry. Investors should carefully consider analyst reports and conduct their own due diligence before investing in CRLBF.

What are the main risks for CRLBF?

The main risks for Cresco Labs include regulatory uncertainty, intense competition, fluctuations in cannabis prices, and limited access to capital. Changes in federal or state cannabis regulations could significantly impact the company's operations and profitability. The cannabis industry is highly competitive, with numerous companies vying for market share. Fluctuations in cannabis prices can affect the company's revenue and margins. Finally, federal cannabis prohibition limits the company's access to traditional banking services and capital markets.

How does Cresco Labs Inc. navigate the complex regulatory landscape of the cannabis industry?

Cresco Labs navigates the complex regulatory landscape by maintaining a dedicated compliance team that monitors and adapts to evolving regulations in each state where it operates. The company invests in robust tracking and tracing systems to ensure compliance with seed-to-sale regulations. Cresco Labs also actively engages with policymakers and industry stakeholders to advocate for responsible cannabis policies. This proactive approach helps the company mitigate regulatory risks and capitalize on emerging opportunities in the cannabis market.

What strategies does Cresco Labs Inc. employ to differentiate its products in a crowded market?

Cresco Labs differentiates its products through a multi-pronged approach. The company focuses on developing a diverse portfolio of brands that cater to different consumer segments and preferences. Cresco Labs also invests in product innovation, developing new and unique cannabis products. The company emphasizes quality and consistency in its cultivation and manufacturing processes. Furthermore, Cresco Labs leverages its retail footprint to provide a positive customer experience and build brand loyalty. These strategies help Cresco Labs stand out in the crowded cannabis market and attract a loyal customer base.

What are the key factors to evaluate for CRLBF?

Cresco Labs Inc. (CRLBF) currently holds an AI score of 45/100, indicating low score. Key strength: Diverse brand portfolio catering to different consumer segments.. Primary risk to monitor: Potential: Regulatory changes could negatively impact the cannabis industry.. This is not financial advice.

How frequently does CRLBF data refresh on this page?

CRLBF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CRLBF's recent stock price performance?

Recent price movement in Cresco Labs Inc. (CRLBF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse brand portfolio catering to different consumer segments.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of 2026-03-16.
  • OTC market data may be less reliable than exchange-listed data.
  • AI analysis pending may provide further insights in the future.
Data Sources

Popular Stocks